{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:17:36Z","timestamp":1767046656218,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":47,"publisher":"ACM","license":[{"start":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T00:00:00Z","timestamp":1471046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["2RO1 GM097618"],"award-info":[{"award-number":["2RO1 GM097618"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["BD2K Initiative: U54 AI117924"],"award-info":[{"award-number":["BD2K Initiative: U54 AI117924"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dl.acm.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,8,13]]},"DOI":"10.1145\/2939672.2939715","type":"proceedings-article","created":{"date-parts":[[2016,8,8]],"date-time":"2016-08-08T18:33:46Z","timestamp":1470681226000},"page":"491-500","update-policy":"https:\/\/doi.org\/10.1145\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Computational Drug Repositioning Using Continuous Self-Controlled Case Series"],"prefix":"10.1145","author":[{"given":"Zhaobin","family":"Kuang","sequence":"first","affiliation":[{"name":"University of Wisconsin, Madison, WI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Thomson","sequence":"additional","affiliation":[{"name":"Morgridge Institute, Madison, WI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Caldwell","sequence":"additional","affiliation":[{"name":"Marshfield Clinic, Marshfield , WI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Peissig","sequence":"additional","affiliation":[{"name":"Marshfield Clinic, Marshfield, WI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Stewart","sequence":"additional","affiliation":[{"name":"Morgridge Institute, Madison, WI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Page","sequence":"additional","affiliation":[{"name":"University of Wisconsin, Madison, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"320","published-online":{"date-parts":[[2016,8,13]]},"reference":[{"key":"e_1_3_2_1_1_1","volume":"200","author":"Ashburn Ted T","unstructured":"Ted T Ashburn and Karl B Thor . Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery , 200 4. Ted T Ashburn and Karl B Thor. Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery, 2004.","journal-title":"Nature Reviews Drug Discovery"},{"key":"e_1_3_2_1_2_1","volume-title":"Clinical Pharmacology & Therapeutics","author":"Hurle MR","year":"2013","unstructured":"MR Hurle , L Yang , Q Xie , DK Rajpal , P Sanseau , and P Agarwal . Computational drug repositioning: from data to therapeutics . Clinical Pharmacology & Therapeutics , 2013 . MR Hurle, L Yang, Q Xie, DK Rajpal, P Sanseau, and P Agarwal. Computational drug repositioning: from data to therapeutics. Clinical Pharmacology & Therapeutics, 2013."},{"key":"e_1_3_2_1_3_1","volume-title":"Briefings in Bioinformatics","author":"Li Jiao","year":"2015","unstructured":"Jiao Li , Si Zheng , Bin Chen , Atul J. Butte , S. Joshua Swamidass , and Zhiyong Lu . A survey of current trends in computational drug repositioning . Briefings in Bioinformatics , 2015 . Jiao Li, Si Zheng, Bin Chen, Atul J. Butte, S. Joshua Swamidass, and Zhiyong Lu. A survey of current trends in computational drug repositioning. Briefings in Bioinformatics, 2015."},{"key":"e_1_3_2_1_4_1","volume":"200","author":"Lamb Justin","unstructured":"Justin Lamb . The connectivity map: a new tool for biomedical research. Nature Reviews Cancer , 200 7. Justin Lamb. The connectivity map: a new tool for biomedical research. Nature Reviews Cancer, 2007.","journal-title":"Nature Reviews Cancer"},{"key":"e_1_3_2_1_5_1","volume-title":"Molecular Systems Biology","author":"Kuhn Michael","year":"2010","unstructured":"Michael Kuhn , Monica Campillos , Ivica Letunic , Lars Juhl Jensen , and Peer Bork . A side effect resource to capture enotypic effects of drugs . Molecular Systems Biology , 2010 . Michael Kuhn, Monica Campillos, Ivica Letunic, Lars Juhl Jensen, and Peer Bork. A side effect resource to capture enotypic effects of drugs. Molecular Systems Biology, 2010."},{"key":"e_1_3_2_1_6_1","volume-title":"Bioinformatics","author":"Liu Yanbin","year":"2010","unstructured":"Yanbin Liu , Bin Hu , Chengxin Fu , and Xin Chen . Dcdb : drug combination database . Bioinformatics , 2010 . Yanbin Liu, Bin Hu, Chengxin Fu, and Xin Chen. Dcdb: drug combination database. Bioinformatics, 2010."},{"key":"e_1_3_2_1_7_1","volume-title":"Nucleic Acids Research","author":"Knox Craig","year":"2011","unstructured":"Craig Knox , Vivian Law , Timothy Jewison , Philip Liu , Son Ly , Alex Frolkis , Allison Pon , Kelly Banco , Christine Mak , Vanessa Neveu , Drugbank 3.0 : a comprehensive resource for omics research on drugs . Nucleic Acids Research , 2011 . Craig Knox, Vivian Law, Timothy Jewison, Philip Liu, Son Ly, Alex Frolkis, Allison Pon, Kelly Banco, Christine Mak, Vanessa Neveu, et al. Drugbank 3.0: a comprehensive resource for omics research on drugs. Nucleic Acids Research, 2011."},{"key":"e_1_3_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2014-002649"},{"key":"e_1_3_2_1_9_1","volume-title":"Biometrics","author":"Simpson Shawn E","year":"2013","unstructured":"Shawn E Simpson , David Madigan , Ivan Zorych , Martijn J Schuemie , Patrick B Ryan , and Marc A Suchard . Multiple self controlled case series for large scale longitudinal observational databases . Biometrics , 2013 . Shawn E Simpson, David Madigan, Ivan Zorych, Martijn J Schuemie, Patrick B Ryan, and Marc A Suchard. Multiple self controlled case series for large scale longitudinal observational databases. Biometrics, 2013."},{"key":"e_1_3_2_1_10_1","volume-title":"Statistics in Medicine","author":"Muggeo Vito MR","year":"2003","unstructured":"Vito MR Muggeo . Estimating regression models with unknown break points . Statistics in Medicine , 2003 . Vito MR Muggeo. Estimating regression models with unknown break points. Statistics in Medicine, 2003."},{"key":"e_1_3_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6180.S7-006"},{"key":"e_1_3_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/jamia.2010.008607"},{"key":"e_1_3_2_1_13_1","volume-title":"White Papers","author":"Ryan PB","year":"2010","unstructured":"PB Ryan . Establishing a drug era persistence window for active surveillance . White Papers , 2010 . PB Ryan. Establishing a drug era persistence window for active surveillance. White Papers, 2010."},{"key":"e_1_3_2_1_14_1","series-title":"Series B (Methodological)","volume-title":"Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society","author":"Tibshirani Robert","year":"1996","unstructured":"Robert Tibshirani . Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society . Series B (Methodological) , 1996 . Robert Tibshirani. Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society. Series B (Methodological), 1996."},{"key":"e_1_3_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511790928"},{"key":"e_1_3_2_1_16_1","unstructured":"AACE. Management of common comorbidities of diabetes. http:\/\/outpatient.aace.com\/type-2-diabetes\/management-of-common-comorbidities-of-diabetes. (Visited on 02\/06\/2016).  AACE. Management of common comorbidities of diabetes. http:\/\/outpatient.aace.com\/type-2-diabetes\/management-of-common-comorbidities-of-diabetes. (Visited on 02\/06\/2016)."},{"key":"e_1_3_2_1_17_1","volume-title":"Statistics in Medicine","author":"Daniel RM","year":"2013","unstructured":"RM Daniel , SN Cousens , De BL Stavola , MG Kenward , and JAC Sterne . Methods for dealing with time dependent confounding . Statistics in Medicine , 2013 . RM Daniel, SN Cousens, De BL Stavola, MG Kenward, and JAC Sterne. Methods for dealing with time dependent confounding. Statistics in Medicine, 2013."},{"key":"e_1_3_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/jamia.2009.002477"},{"key":"e_1_3_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.04037.x"},{"key":"e_1_3_2_1_20_1","volume-title":"http:\/\/omop.org\/sites\/default\/files\/ground%20truth.pdf","author":"OMOP.","year":"2015","unstructured":"OMOP. Ground truth for monitoring health outcomes of interest. http:\/\/omop.org\/sites\/default\/files\/ground%20truth.pdf , 2015 . ( Visited on 09\/28\/2015). OMOP. Ground truth for monitoring health outcomes of interest. http:\/\/omop.org\/sites\/default\/files\/ground%20truth.pdf, 2015. (Visited on 09\/28\/2015)."},{"key":"e_1_3_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1109\/TIT.2009.2016018"},{"key":"e_1_3_2_1_22_1","unstructured":"DiabetesInControl. Drugs that can affect blood glucose levels. http:\/\/www.diabetesincontrol.com\/wp-content\/uploads\/2010\/07\/www.diabetesincontrol.com_images_tools_druglistaffectingbloodglucose.pdf 2015. (Visited on 09\/28\/2015).  DiabetesInControl. Drugs that can affect blood glucose levels. http:\/\/www.diabetesincontrol.com\/wp-content\/uploads\/2010\/07\/www.diabetesincontrol.com_images_tools_druglistaffectingbloodglucose.pdf 2015. (Visited on 09\/28\/2015)."},{"key":"e_1_3_2_1_23_1","volume-title":"Diabetes Care","author":"Lustman Patrick J","year":"2007","unstructured":"Patrick J Lustman , Monique M Williams , Gregory S Sayuk , Billy D Nix , and Ray E Clouse . Factors influencing glycemic control in type 2 diabetes during acute-and maintenance-phase treatment of major depressive disorder with bupropion . Diabetes Care , 2007 . Patrick J Lustman, Monique M Williams, Gregory S Sayuk, Billy D Nix, and Ray E Clouse. Factors influencing glycemic control in type 2 diabetes during acute-and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care, 2007."},{"key":"e_1_3_2_1_24_1","volume-title":"Infectious Disease Clinics of North America","author":"Vazquez Jose A","year":"1995","unstructured":"Jose A Vazquez and Jack D Sobel . Fungal infections in diabetes . Infectious Disease Clinics of North America , 1995 . Jose A Vazquez and Jack D Sobel. Fungal infections in diabetes. Infectious Disease Clinics of North America, 1995."},{"key":"e_1_3_2_1_25_1","unstructured":"ADA. Skin complications. http:\/\/www.diabetes.org\/living-with-diabetes\/complications\/skin-complications.html?referrer=https:\/\/www.google.com\/. (Visited on 01\/19\/2016).  ADA. Skin complications. http:\/\/www.diabetes.org\/living-with-diabetes\/complications\/skin-complications.html?referrer=https:\/\/www.google.com\/. (Visited on 01\/19\/2016)."},{"key":"e_1_3_2_1_26_1","unstructured":"CDC. Smoking and diabetes. http:\/\/www.cdc.gov\/tobacco\/campaign\/tips\/diseases\/diabetes.html. (Visited on 01\/19\/2016).  CDC. Smoking and diabetes. http:\/\/www.cdc.gov\/tobacco\/campaign\/tips\/diseases\/diabetes.html. (Visited on 01\/19\/2016)."},{"key":"e_1_3_2_1_27_1","volume-title":"Circulation","author":"Vermes Emmanuelle","year":"2003","unstructured":"Emmanuelle Vermes , Anique Ducharme , Martial G Bourassa , Myriam Lessard , Michel White , and Jean-Claude Tardif . Enalapril reduces the incidence of diabetes in patients with chronic heart failure insight from the studies of left ventricular dysfunction (solvd) . Circulation , 2003 . Emmanuelle Vermes, Anique Ducharme, Martial G Bourassa, Myriam Lessard, Michel White, and Jean-Claude Tardif. Enalapril reduces the incidence of diabetes in patients with chronic heart failure insight from the studies of left ventricular dysfunction (solvd). Circulation, 2003."},{"key":"e_1_3_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0953-6205(03)90001-X"},{"key":"e_1_3_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2014.08.008"},{"key":"e_1_3_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/5.4.431"},{"key":"e_1_3_2_1_31_1","volume-title":"Archives of Internal Medicine","author":"Zhao-Wei Ting Rose","year":"2006","unstructured":"Rose Zhao-Wei Ting , Cheuk Chun Szeto , Michael Ho-Ming Chan , Kwok Kuen Ma , and Kai Ming Chow . Risk factors of vitamin b12 deficiency in patients receiving metformin . Archives of Internal Medicine , 2006 . Rose Zhao-Wei Ting, Cheuk Chun Szeto, Michael Ho-Ming Chan, Kwok Kuen Ma, and Kai Ming Chow. Risk factors of vitamin b12 deficiency in patients receiving metformin. Archives of Internal Medicine, 2006."},{"key":"e_1_3_2_1_32_1","volume-title":"Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences","author":"Kesim Murat","year":"2011","unstructured":"Murat Kesim , Ahmet Tiryaki , Mine Kadioglu , Efnan Muci , Nuri Ihsan Kalyoncu , and Ersin Yaris . The effects of sertraline on blood lipids, glucose, insulin and hba1c levels: A prospective clinical trial on depressive patients . Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences , 2011 . Murat Kesim, Ahmet Tiryaki, Mine Kadioglu, Efnan Muci, Nuri Ihsan Kalyoncu, and Ersin Yaris. The effects of sertraline on blood lipids, glucose, insulin and hba1c levels: A prospective clinical trial on depressive patients. Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences, 2011."},{"key":"e_1_3_2_1_33_1","volume-title":"Diabetes Care","author":"Kodama Junichi","year":"1990","unstructured":"Junichi Kodama , Shigehiro Katayama , Kiyoshi Tanaka , Akira Itabashi , Shyoji Kawazu , and Jun Ishii . Effect of captopril on glucose concentration: possible role of augmented postprandial forearm blood flow . Diabetes Care , 1990 . Junichi Kodama, Shigehiro Katayama, Kiyoshi Tanaka, Akira Itabashi, Shyoji Kawazu, and Jun Ishii. Effect of captopril on glucose concentration: possible role of augmented postprandial forearm blood flow. Diabetes Care, 1990."},{"key":"e_1_3_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb1978.3.395"},{"key":"e_1_3_2_1_35_1","unstructured":"FDA. Consumer updates: FDA expands advice on statin risks. http:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm293330.htm 2014. (Visited on 09\/28\/2015).  FDA. Consumer updates: FDA expands advice on statin risks. http:\/\/www.fda.gov\/ForConsumers\/ConsumerUpdates\/ucm293330.htm 2014. (Visited on 09\/28\/2015)."},{"key":"e_1_3_2_1_36_1","volume-title":"Circulation","author":"Freeman Dilys J","year":"2001","unstructured":"Dilys J Freeman , John Norrie , Naveed Sattar , R Dermot G Neely , Stuart M Cobbe , Ian Ford , Christopher Isles , A Ross Lorimer , Peter W Macfarlane , James H McKillop , Pravastatin and the development of diabetes mellitus evidence for a protective treatment effect in the west of scotland coronary prevention study . Circulation , 2001 . Dilys J Freeman, John Norrie, Naveed Sattar, R Dermot G Neely, Stuart M Cobbe, Ian Ford, Christopher Isles, A Ross Lorimer, Peter W Macfarlane, James H McKillop, et al. Pravastatin and the development of diabetes mellitus evidence for a protective treatment effect in the west of scotland coronary prevention study. Circulation, 2001."},{"key":"e_1_3_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2610"},{"key":"e_1_3_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1159\/000100369"},{"key":"e_1_3_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12548"},{"key":"e_1_3_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.4021\/jocmr890w"},{"key":"e_1_3_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2011.02680.x"},{"key":"e_1_3_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/147323000403200214"},{"key":"e_1_3_2_1_43_1","unstructured":"FDA. Premarin (conjugated estrogens tablets usp). http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2006\/004782s147lbl.pdf. (Visited on 02\/08\/2016).  FDA. Premarin (conjugated estrogens tablets usp). http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2006\/004782s147lbl.pdf. (Visited on 02\/08\/2016)."},{"key":"e_1_3_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197909133011108"},{"key":"e_1_3_2_1_45_1","volume-title":"Turnover of low density lipoproteins during inhibition of cholesterol absorption by neomycin. Arteriosclerosis, Thrombosis, and Vascular Biology","author":"Kesaniemi YA","year":"1984","unstructured":"YA Kesaniemi and Scott M Grundy . Turnover of low density lipoproteins during inhibition of cholesterol absorption by neomycin. Arteriosclerosis, Thrombosis, and Vascular Biology , 1984 . YA Kesaniemi and Scott M Grundy. Turnover of low density lipoproteins during inhibition of cholesterol absorption by neomycin. Arteriosclerosis, Thrombosis, and Vascular Biology, 1984."},{"key":"e_1_3_2_1_46_1","volume-title":"Metabolism","author":"Jenkins David JA","year":"2005","unstructured":"David JA Jenkins , Cyril WC Kendall , Maryam Hamidi , Edward Vidgen , Dorothea Faulkner , Tina Parker , Nalini Irani , Thomas MS Wolever , Ignatius Fong , Peter Kopplin , Effect of antibiotics as cholesterol-lowering agents . Metabolism , 2005 . David JA Jenkins, Cyril WC Kendall, Maryam Hamidi, Edward Vidgen, Dorothea Faulkner, Tina Parker, Nalini Irani, Thomas MS Wolever, Ignatius Fong, Peter Kopplin, et al. Effect of antibiotics as cholesterol-lowering agents. Metabolism, 2005."},{"key":"e_1_3_2_1_47_1","volume-title":"The self-controlled case series: Recent developments. Submitted","author":"Madigan David","year":"2015","unstructured":"David Madigan , Shawn Simpson , Wei Hua , Antonio Paredes , Bruce Fireman , and Malcolm Maclure . The self-controlled case series: Recent developments. Submitted , 2015 . URL http:\/\/www.stat.columbia.edu\/ madigan\/PAPERS\/DrugSafety.pdf. David Madigan, Shawn Simpson, Wei Hua, Antonio Paredes, Bruce Fireman, and Malcolm Maclure. The self-controlled case series: Recent developments. Submitted, 2015. URL http:\/\/www.stat.columbia.edu\/ madigan\/PAPERS\/DrugSafety.pdf."}],"event":{"name":"KDD '16: The 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining","sponsor":["SIGMOD ACM Special Interest Group on Management of Data","SIGKDD ACM Special Interest Group on Knowledge Discovery in Data"],"location":"San Francisco California USA","acronym":"KDD '16"},"container-title":["Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/2939672.2939715","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/2939672.2939715","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:55:57Z","timestamp":1750222557000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/2939672.2939715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,13]]},"references-count":47,"alternative-id":["10.1145\/2939672.2939715","10.1145\/2939672"],"URL":"https:\/\/doi.org\/10.1145\/2939672.2939715","relation":{},"subject":[],"published":{"date-parts":[[2016,8,13]]},"assertion":[{"value":"2016-08-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}